• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过蛋白质组学分析检测甲状腺肿瘤组织中组织蛋白酶B的上调。

Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis.

作者信息

Srisomsap Chantragan, Subhasitanont Pantipa, Otto Albrecht, Mueller Eva-Christina, Punyarit Phaibul, Wittmann-Liebold Brigitte, Svasti Jisnuson

机构信息

Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok, Thailand.

出版信息

Proteomics. 2002 Jun;2(6):706-12. doi: 10.1002/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E.

DOI:10.1002/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E
PMID:12112852
Abstract

Nodular or multinodular goiter is the most common non-neoplastic thyroid disease and may be difficult to distinguish from true neoplastic thyroid diseases using microscopic criteria. We have used two-dimensional gel electrophoresis to study the protein patterns of thyroid tissues including normal thyroid, multinodular goiter, diffuse hyperplasia, follicular adenoma, follicular carcinoma and papillary carcinoma. Specific proteins, in the region of molecular mass 15-30 kDa and isoelectric point 4.5-6.5, were identified by electrospray tandem mass spectrometry and protein sequencing. The most distinctive protein found is cathepsin B, which could be detected as four spots, with differential expression in different thyroid diseases. In particular, two of these cathepsin B spots CB2 and CB3 are strongly up-regulated in neoplastic diseases, compared to non-neoplastic diseases. In addition, overexpression of ATP synthase D chain and prohibitin were observed in papillary carcinoma, which should allow it to be differentiated from follicular carcinoma. Changes in expression of other proteins were also observed in disease states compared to normal tissues, namely translationally controlled tumor protein, thioredoxin peroxidase 1, glutathione-S-transferase P, DJ-1 protein, superoxide dismutase (Cu, Zn), and heat shock protein 27, but these changes are less characteristic, so they do not allow the differentiation between neoplastic and non-neoplastic tissues. Thus, the proteomic approach is a useful diagnostic tool for studying diseases involving the thyroid nodule.

摘要

结节性或多结节性甲状腺肿是最常见的非肿瘤性甲状腺疾病,使用显微镜标准可能难以与真正的肿瘤性甲状腺疾病区分开来。我们使用二维凝胶电泳研究了包括正常甲状腺、多结节性甲状腺肿、弥漫性增生、滤泡性腺瘤、滤泡性癌和乳头状癌在内的甲状腺组织的蛋白质模式。通过电喷雾串联质谱和蛋白质测序鉴定了分子量在15 - 30 kDa之间、等电点在4.5 - 6.5之间的特定蛋白质。发现的最具特色的蛋白质是组织蛋白酶B,它可以被检测为四个斑点,在不同的甲状腺疾病中表达存在差异。特别是,与非肿瘤性疾病相比,这些组织蛋白酶B斑点中的两个,即CB2和CB3,在肿瘤性疾病中强烈上调。此外,在乳头状癌中观察到ATP合酶D链和抑制素的过表达,这应该有助于将其与滤泡性癌区分开来。与正常组织相比,在疾病状态下还观察到其他蛋白质表达的变化,即翻译控制肿瘤蛋白、硫氧还蛋白过氧化物酶1、谷胱甘肽 - S - 转移酶P、DJ - 1蛋白、超氧化物歧化酶(铜,锌)和热休克蛋白27,但这些变化的特征性较差,因此它们无法区分肿瘤性和非肿瘤性组织。因此,蛋白质组学方法是研究涉及甲状腺结节疾病的一种有用的诊断工具。

相似文献

1
Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis.通过蛋白质组学分析检测甲状腺肿瘤组织中组织蛋白酶B的上调。
Proteomics. 2002 Jun;2(6):706-12. doi: 10.1002/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E.
2
Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma.蛋白质组分析确定了乳腺丝抑蛋白是甲状腺乳头状癌的一个特殊特征。
Int J Oncol. 2003 Nov;23(5):1323-8.
3
The expression and role of serum response factor in papillary carcinoma of the thyroid.血清反应因子在甲状腺乳头状癌中的表达及作用
Int J Oncol. 2009 Jul;35(1):49-55.
4
Two-dimensional electrophoretic analysis of membranous protein from human thyroid tissues and cancer cell lines.人甲状腺组织和癌细胞系膜蛋白的二维电泳分析
Electrophoresis. 1998 Dec;19(18):3213-6. doi: 10.1002/elps.1150191826.
5
A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.多结节性甲状腺肿和甲状腺乳头状癌患者甲状腺转录因子-1(TITF-1/NKX2.1)中的种系突变(A339V)
J Natl Cancer Inst. 2009 Feb 4;101(3):162-75. doi: 10.1093/jnci/djn471. Epub 2009 Jan 27.
6
Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.CD56免疫组化在甲状腺乳头状癌中的诊断效用
Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.
7
Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.中国队列中肝细胞癌的蛋白质组学分析揭示了热休克蛋白(Hsp27、Hsp70、GRP78)的上调及其相关的预后价值。
Proteomics. 2006 Feb;6(3):1049-57. doi: 10.1002/pmic.200500306.
8
Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.通过二维差异凝胶电泳和质谱法鉴定人肝细胞癌相关生物标志物
J Proteome Res. 2005 Nov-Dec;4(6):2062-9. doi: 10.1021/pr0502018.
9
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.半乳糖凝集素-3不能可靠地区分甲状腺良性和恶性肿瘤。
Histopathology. 2004 Nov;45(5):493-500. doi: 10.1111/j.1365-2559.2004.01978.x.
10
Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.中东地区乳头状甲状腺癌的全基因组表达分析揭示c-MET是癌症治疗的新靶点。
J Pathol. 2007 Oct;213(2):190-9. doi: 10.1002/path.2215.

引用本文的文献

1
Cathepsin B in urological tumors: unraveling its role and therapeutic potential.泌尿肿瘤中的组织蛋白酶B:揭示其作用和治疗潜力。
Discov Oncol. 2025 May 9;16(1):707. doi: 10.1007/s12672-025-02552-w.
2
Emerging roles of prohibitins in cancer: an update.抑制素在癌症中的新作用:最新进展
Cancer Gene Ther. 2025 Apr;32(4):357-370. doi: 10.1038/s41417-025-00883-y. Epub 2025 Mar 8.
3
Secreted and surface proteome and transcriptome of ..的分泌蛋白质组、表面蛋白质组和转录组
Front Parasitol. 2023 Oct 10;2:1195457. doi: 10.3389/fpara.2023.1195457. eCollection 2023.
4
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics.通过多组学洞察甲状腺乳头状癌的新型生物标志物
Front Oncol. 2023 Sep 19;13:1269751. doi: 10.3389/fonc.2023.1269751. eCollection 2023.
5
Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells.Mucin 1 作为新型二异喹啉衍生物与抗 MUC1 抗体在 AGS 胃癌细胞中的结合的分子靶点。
Molecules. 2021 Oct 28;26(21):6504. doi: 10.3390/molecules26216504.
6
Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer.组织病理学分析组织蛋白酶 B 作为甲状腺癌的预后标志物。
Int J Mol Sci. 2020 Dec 15;21(24):9537. doi: 10.3390/ijms21249537.
7
Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes.组织蛋白酶B在胰腺癌干细胞样细胞中高表达,并与患者的手术结果相关。
Oncol Lett. 2021 Jan;21(1):30. doi: 10.3892/ol.2020.12291. Epub 2020 Nov 11.
8
Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen.利用实验小鼠模型鉴定由HBx抗原诱导的肝细胞癌效应因子。
Cancers (Basel). 2020 Feb 10;12(2):409. doi: 10.3390/cancers12020409.
9
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.甲状腺乳头状癌:遗传改变与分子生物标志物研究。
Int J Med Sci. 2019 Feb 28;16(3):450-460. doi: 10.7150/ijms.29935. eCollection 2019.
10
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer.血清组织蛋白酶B和胱抑素C水平及其比值在食管癌患者预后中的临床意义
Onco Targets Ther. 2017 Apr 3;10:1947-1954. doi: 10.2147/OTT.S123042. eCollection 2017.